Joshua Tisdell Schiffer MD
Instructor, Medicine, University of Washington School of Medicine
Join to View Full Profile
1959 NE Pacific StSeattle, WA 98195
Phone+1 206-288-1000
Fax+1 206-606-1025
Dr. Schiffer is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
University of WashingtonFellowship, Infectious Disease, 2005 - 2009
Johns Hopkins UniversityResidency, Internal Medicine, 2002 - 2005- Johns Hopkins University School of MedicineClass of 2002
Certifications & Licensure
WA State Medical License 2005 - 2028
AK State Medical License 2023 - 2024
MD State Medical License 2006 - 2007
American Board of Internal Medicine Infectious Disease
Clinical Trials
- MMF for HIV Reservoir Reduction Start of enrollment: 2018 Feb 12
Publications & Presentations
PubMed
- Clinical trial simulation of antiviral drugs.Joshua T Schiffer, Daniel B Reeves, Bryan Mayer, Lucero Rodriguez Rodriguez, Elizabeth R Duke
Journal of Virology. 2026-05-19 - Is it "time to eliminate" time to elimination of symptoms as a primary trial endpoint for respiratory virus targeting drugs?Joshua T Schiffer, Shadisadat Esmaeili, Katherine Owens, Michael Boeckh, Alpana Waghmare
The Journal of Infectious Diseases. 2026-03-07 - Research In Your Mailbox: Remote Blood Self-sampling Enables Participation of Underserved Populations in Longitudinal Studies.Filip Stefanovic, Ingrid Robertson, Kathleen Moloney, Jane Edelson, Serena Nguyen
Medrxiv. 2026-02-06
Journal Articles
- A Fixed Spatial Structure of CD8+ T Cells in Tissue During Chronic HSV-2 InfectionJoshua Schiffer, MD, The Journal of Immunology
Press Mentions
Do COVID-19 Tests Still Work?February 10th, 2025- Should You Still Be Wearing a Mask? As COVID Rates Climb, Health Experts Say the Answer Is YesJuly 28th, 2022
- Moderna's Spikevax Scores Full FDA Approval While Omicron BA.2 Picture EmergesJanuary 31st, 2022
Grant Support
- Early intervention with anti-proliferative therapy close to ART initiation to limit long-term SIV persistenceFRED HUTCHINSON CANCER CENTER2024–2029
- Development of an Oral Pan-Coronavirus Drug CocktailUNIVERSITY OF WASHINGTON2023–2028
- Characterizing determinants of primary KSHV infection among children and adolescents in UgandaFRED HUTCHINSON CANCER CENTER2019–2025
- Mathematical modeling of optimal therapeutic combinations for HIV cureFRED HUTCHINSON CANCER CENTER2019–2025
- Intense Validation Of A Mathematical Model Of Herpes Simplex Virus-2 PathogenesisNational Institute Of Allergy And Infectious Diseases2010–2012
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
